Extended wearing trial of Trifield lens device for 'tunnel vision'

Severe visual field constriction (tunnel vision) impairs the ability to navigate and walk safely. We evaluated Trifield glasses as a mobility rehabilitation device for tunnel vision in an extended wearing trial. Twelve patients with tunnel vision (5-22 degrees wide) due to retinitis pigmentosa or choroideremia participated in the 5-visit wearing trial. To expand the horizontal visual field, one spectacle lens was fitted with two apex-to-apex prisms that vertically bisected the pupil on primary gaze. This provides visual field expansion at the expense of visual confusion (two objects with the same visual direction). Patients were asked to wear these spectacles as much as possible for the duration of the wearing trial (median 8, range 6-60 weeks). Clinical success (continued wear, indicating perceived overall benefit), visual field expansion, perceived direction and perceived visual ability were measured. Of 12 patients, nine chose to continue wearing the Trifield glasses at the end of the wearing trial. Of those nine patients, at long-term follow-up (35-78 weeks), three reported still wearing the Trifield glasses. Visual field expansion (median 18, range 9-38 degrees) was demonstrated for all patients. No patient demonstrated adaptation to the change in visual direction produced by the Trifield glasses (prisms). For reported difficulty with obstacles, some differences between successful and non-successful wearers were found. Trifield glasses provided reported benefits in obstacle avoidance to 7 of the 12 patients completing the wearing trial. Crowded environments were particularly difficult for most wearers. Possible reasons for long-term discontinuation and lack of adaptation to perceived direction are discussed.

A curriculum for training patients with peripheral visual field loss to use bioptic amorphic lenses

This article describes the experimental protocol used to instruct fifteen patients with peripheral visual field loss due to retinitis pigmentosa, choroideremia, or Usher's syndrome Type II how to effectively use bioptic amorphic lenses. The factors that contributed to the successful use of these lenses, as well as difficulties the patients encountered, are discussed. The results of the study (published in detail in Szlyk et al. Use of bioptic amorphic lenses to expand the visual field in patients with peripheral loss. Optom Vis Sci 1998;75:518-24) indicate that bioptic amorphic lenses, when combined with a comprehensive training program, can expand visual function in the areas of peripheral detection, recognition, scanning, tracking, visual memory, and mobility.